1. The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases
   Liang Zhou et al, 2022, Journal of Molecular Biology CrossRef
2. Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
   Sara Moodad et al, 2020, Cancers CrossRef
3. Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myeloma
   Xiaojia Zuo et al, 2022, Hematology CrossRef
4. Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules
   Raman Kumar et al, 2018, Molecular Biology Reports CrossRef
5. Arsenic-Based Anticancer-Combined Therapy: Novel Mechanism Inducing Apoptosis of Cancer Cells
   Akinobu Ota et al, 2018, Current Understanding of Apoptosis - Programmed Cell Death CrossRef
6. Endoplasmic Reticulum Stress-Mediated p62 Downregulation Inhibits Apoptosis via c-Jun Upregulation
   Wenjun Yu et al, 2021, Biomolecules & Therapeutics CrossRef
7. Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
   Phoebe A. Huang et al, 2019, Scientific Reports CrossRef
8. Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma
   Liang Zhou, 2022, Frontiers in Oncology CrossRef
9. Modulation of Different Signaling Pathways in Liver Cancer by Arsenic Trioxide
   Archana Chaudhary et al, 2023, Arsenic Toxicity Remediation: Biotechnological Approaches CrossRef
10. Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide
    Yuxin Liu et al, 2024, Expert Review of Hematology CrossRef
11. Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon
    Busong Wang et al, 2024, Cellular and Molecular Life Sciences CrossRef